Primary prevention of coronary artery disease among middle aged men in Prague: twenty-year follow-up results. 2006

F Boudík, and J Reissigová, and K Hrach, and M Tomecková, and J Bultas, and Z Anger, and M Aschermann, and J Zvárová
2nd Department of Internal Medicine, Charles University Hospital, U nemocnice 2, Prague 2, Czech Republic. fboud@lf1.cuni.cz

BACKGROUND Coronary artery disease (CAD) represents the most common cause of morbidity and mortality in the Czech Republic. The aim of this study is to analyze long-term cardiovascular diseases (CVD) mortality, identify predictors of outcome and to validate the Framingham risk function in men from the Czech Republic. METHODS A 20-year primary prevention study of atherosclerosis risk factors in 1417 men from Prague aged 38-53 years was launched in 1975 (STULONG). RESULTS When analyzing CVD mortality, heavy smokers had hazard higher than non-smokers and light smokers (p < 0.0001); hypertensives higher than normotensives (p < 0.0001); men with hypercholesterolemia higher than those with normal cholesterol (p = 0.0432), and university-educated men lower than elementary-educated men (p = 0.0006). In 1980-1984, the age specific mortality from CVD in men from STULONG was higher (p = 0.0132) than in the Czech Republic, in 1985-1994 insignificantly lower. The Framingham risk function underestimated the absolute 10-year risk of CAD across the quintile of the risk (p < 0.0001), with 63% discrimination. CONCLUSIONS In STULONG, the mortality from CVD was significantly associated with known risk factors (hypertension, smoking, hypercholesterolemia, education); the Framingham risk function underestimated the absolute 10-year risk of CAD.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D011322 Primary Prevention Specific practices for the prevention of disease or mental disorders in susceptible individuals or populations. These include HEALTH PROMOTION, including mental health; protective procedures, such as COMMUNICABLE DISEASE CONTROL; and monitoring and regulation of ENVIRONMENTAL POLLUTANTS. Primary prevention is to be distinguished from SECONDARY PREVENTION and TERTIARY PREVENTION. Prevention, Primary,Disease Prevention, Primary,Prevention, Primordial,Primordial Prevention,Disease Preventions, Primary,Preventions, Primordial,Primary Disease Prevention,Primary Disease Preventions,Primordial Preventions
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D003324 Coronary Artery Disease Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause. Arteriosclerosis, Coronary,Atherosclerosis, Coronary,Coronary Arteriosclerosis,Coronary Atherosclerosis,Left Main Coronary Artery Disease,Left Main Coronary Disease,Left Main Disease,Arterioscleroses, Coronary,Artery Disease, Coronary,Artery Diseases, Coronary,Atheroscleroses, Coronary,Coronary Arterioscleroses,Coronary Artery Diseases,Coronary Atheroscleroses,Left Main Diseases
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006937 Hypercholesterolemia A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population. Hypercholesteremia,Elevated Cholesterol,High Cholesterol Levels,Cholesterol Level, High,Cholesterol Levels, High,Cholesterol, Elevated,Cholesterols, Elevated,Elevated Cholesterols,High Cholesterol Level,Hypercholesteremias,Hypercholesterolemias,Level, High Cholesterol,Levels, High Cholesterol

Related Publications

F Boudík, and J Reissigová, and K Hrach, and M Tomecková, and J Bultas, and Z Anger, and M Aschermann, and J Zvárová
August 1998, Circulation,
F Boudík, and J Reissigová, and K Hrach, and M Tomecková, and J Bultas, and Z Anger, and M Aschermann, and J Zvárová
September 1983, Circulation,
F Boudík, and J Reissigová, and K Hrach, and M Tomecková, and J Bultas, and Z Anger, and M Aschermann, and J Zvárová
September 1995, American journal of public health,
F Boudík, and J Reissigová, and K Hrach, and M Tomecková, and J Bultas, and Z Anger, and M Aschermann, and J Zvárová
January 2008, Blood pressure,
F Boudík, and J Reissigová, and K Hrach, and M Tomecková, and J Bultas, and Z Anger, and M Aschermann, and J Zvárová
November 2000, Italian heart journal : official journal of the Italian Federation of Cardiology,
F Boudík, and J Reissigová, and K Hrach, and M Tomecková, and J Bultas, and Z Anger, and M Aschermann, and J Zvárová
January 1976, Acta medica Scandinavica,
F Boudík, and J Reissigová, and K Hrach, and M Tomecková, and J Bultas, and Z Anger, and M Aschermann, and J Zvárová
October 2015, BMC cardiovascular disorders,
F Boudík, and J Reissigová, and K Hrach, and M Tomecková, and J Bultas, and Z Anger, and M Aschermann, and J Zvárová
December 2008, Pharmacy world & science : PWS,
F Boudík, and J Reissigová, and K Hrach, and M Tomecková, and J Bultas, and Z Anger, and M Aschermann, and J Zvárová
November 1975, Acta medica Scandinavica,
F Boudík, and J Reissigová, and K Hrach, and M Tomecková, and J Bultas, and Z Anger, and M Aschermann, and J Zvárová
December 1993, JAMA,
Copied contents to your clipboard!